316 related articles for article (PubMed ID: 38699583)
1. Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation.
Zhang Y; Zhang XY; Shi SR; Ma CN; Lin YP; Song WG; Guo SD
Front Cardiovasc Med; 2024; 11():1372055. PubMed ID: 38699583
[TBL] [Abstract][Full Text] [Related]
2. Targeting PPARs for therapy of atherosclerosis: A review.
Miao M; Wang X; Liu T; Li YJ; Yu WQ; Yang TM; Guo SD
Int J Biol Macromol; 2023 Jul; 242(Pt 2):125008. PubMed ID: 37217063
[TBL] [Abstract][Full Text] [Related]
3. Marine Natural and Nature-Inspired Compounds Targeting Peroxisome Proliferator Activated Receptors (PPARs).
D'Aniello E; Amodeo P; Vitale RM
Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827130
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
5. The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.
Escandon P; Vasini B; Whelchel AE; Nicholas SE; Matlock HG; Ma JX; Karamichos D
Exp Eye Res; 2021 Jul; 208():108617. PubMed ID: 34010603
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease.
Wagner N; Wagner KD
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768666
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice.
Yang X; Wang J; Chang CY; Zhou F; Liu J; Xu H; Ibrahim M; Gomez M; Guo GL; Liu H; Zong WX; Wondisford FE; Su X; White E; Feng Z; Hu W
Nat Commun; 2024 Jan; 15(1):627. PubMed ID: 38245529
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Impact of Omega-3 Fatty Acid (Soloways
Pokushalov E; Ponomarenko A; Bayramova S; Garcia C; Pak I; Shrainer E; Voronina E; Sokolova E; Johnson M; Miller R
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201926
[TBL] [Abstract][Full Text] [Related]
9. Targeting PPARγ/ NF-κB Signaling Pathway by Britannin, a Sesquiterpene Lactone from
Abdolmohammadi MH; Roozbehani M; Hamzeloo-Moghadam M; Heidari F; Fallahian F
Anticancer Agents Med Chem; 2023; 23(19):2102-2110. PubMed ID: 37723632
[TBL] [Abstract][Full Text] [Related]
10. Proanthocyanidin Alleviates Liver Ischemia/Reperfusion Injury by Suppressing Autophagy and Apoptosis via the PPARα/PGC1α Signaling Pathway.
Yao Z; Liu N; Lin H; Zhou Y
J Clin Transl Hepatol; 2023 Nov; 11(6):1329-1340. PubMed ID: 37719964
[TBL] [Abstract][Full Text] [Related]
11. Roles of citrus fruits on energy expenditure, body weight management, and metabolic biomarkers: a comprehensive review.
Aslan MN; Sukan-Karaçağıl B; Acar-Tek N
Nutr Rev; 2023 Sep; ():. PubMed ID: 37702528
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacokinetics-related pharmacological effects of orally administered polysaccharides from traditional Chinese medicines: A review.
Ye D; Zhao Q; Ding D; Ma BL
Int J Biol Macromol; 2023 Dec; 252():126484. PubMed ID: 37625759
[TBL] [Abstract][Full Text] [Related]
13. Proanthocyanidin A2 attenuates the activation of hepatic stellate cells by activating the PPAR-γ signalling pathway.
Xiao Y; Li X; Wang L; Hu M; Liu Y
Autoimmunity; 2023 Dec; 56(1):2250101. PubMed ID: 37615088
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
